Pharmaceutical Business review

Schering-Plough Q1 net income surges

The company has reported net income available to common shareholders of $767 million for the first quarter of 2009 compared to $276 million for the same quarter of 2008.

For the first quarter of 2009, net sales were $4.39 billion, compared to $4.66 billion in the same quarter of 2008.

Fred Hassan, chairman and CEO of Schering-Plough, said: “Schering-Plough powered through to deliver a solid performance in the first quarter. We overcame difficult currency comparisons and challenges in the US by driving operational sales growth in overseas markets and the continuing successful implementation of our Productivity Transformation Program.”